Compare Kimberly Clark Corp (KMB) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kimberly Clark Corp vs Smith & Nephew plc — how do they compare? Kimberly Clark Corp trades at $108.18 (market cap $36.01B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Kimberly Clark Corp is far larger — about 2.8× Smith & Nephew plc's market cap, and Kimberly Clark Corp pays the higher dividend (4.72%). Which is the better fit depends on your goals.
| KMB | SNN | |
|---|---|---|
Market Cap | $36.01B | $12.64B |
Sector | Consumer Staples | Health |
52-Week High | $136.77 | $38.70 |
52-Week Low | $93.05 | $28.73 |
Enterprise Value | $42.55B | $15.41B |
Dividend Yield | 4.72% | 2.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
